glp 1 receptor antagonists Evolution of GLP‐1 Agonists for Diabetes Treatment Frontiers | Mechanisms of action

GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials

CM contributed to the design of the study, construction of the model, interpretation of the data, and revision of the manuscript

In Study F, there were 10% of subjects in the TRESIBA and 6.8% Insulin glargine arms for whom data was missing at the time of the HbA1c measurement

In pediatric patients with genetic obesity, such as those carrying the PNPLA3 p.I148 M variant, bariatric surgery may yield greater liver fat reduction, as observed in a study showing more substantial improvements in liver fat content among PNPLA3-associated steatohepatitis patients compared to non-carriers [207]